Skip to content
Clinical Trials – home

Peripheral arterial occlusive disease Treatment

12 / 17 trials open to patients17 countries

In short

Peripheral arterial occlusive disease is a condition where arteries in the limbs become narrowed or blocked, making it harder for blood to reach muscles and tissues. Modern treatment options aim to relieve symptoms like leg pain, slow disease progression, and prevent serious complications such as tissue loss or limb amputation.

Key points

  • Quitting smoking is the single most powerful thing you can do to stop PAD from progressing and protect your overall health.
  • Walking until you feel pain, resting, and then walking again can actually help reduce leg pain over time through supervised exercise programs.
  • Having PAD means your blood vessels throughout your body are likely unhealthy, putting you at higher risk for heart attack and stroke.
  • More than half of an artery must be blocked before symptoms appear, so some people have significant disease without knowing it.
  • Medications like statins and blood pressure drugs are not just treating your legs but protecting your heart and brain as well.
  • Minimally invasive procedures like angioplasty can often restore blood flow without major surgery and require only a short recovery period.
  • Clinical trials are testing new drug-coated stents and balloons that may help keep arteries open longer after procedures.
  • Sudden severe leg pain with skin color changes is a medical emergency that requires immediate treatment to save the limb.

How doctors help patients manage blocked arteries in the legs

When arteries in the legs become narrowed or blocked, the main goal of treatment is to help patients live more comfortably while reducing the risk of serious health problems. Peripheral arterial occlusive disease, often called PAD, affects how much blood flows to the legs and feet. Treatment focuses on easing symptoms like leg pain during walking, improving the ability to move around and perform daily activities, and preventing complications that could threaten the leg or even life itself.

The approach to treating this condition depends on several factors. Doctors consider how severe the blockage is, which arteries are affected, whether the patient has other health conditions like diabetes or high blood pressure, and how much the symptoms interfere with daily life. Some people experience only mild discomfort when walking, while others may have pain even when resting or develop wounds that do not heal properly.

Standard treatments that have been used for many years include lifestyle changes, medications, and procedures to open or bypass blocked arteries. At the same time, researchers are testing new approaches in clinical trials, exploring innovative ways to improve blood flow and help patients feel better. Because PAD often signals that blood vessels throughout the body are unhealthy, treatment also aims to protect the heart and brain from complications like heart attacks and strokes.

Standard treatment approaches for peripheral arterial occlusive disease

The foundation of treating peripheral arterial occlusive disease involves making important changes to daily habits and taking medications that address the underlying causes of artery narrowing. These treatments are recommended by medical societies and have been shown to help patients manage their symptoms and reduce the risk of serious complications.

Lifestyle modifications form the cornerstone of managing PAD. Quitting smoking is perhaps the most critical step anyone with this condition can take. Smoking is the single most significant risk factor for PAD, and continuing to smoke after diagnosis greatly increases the chances of the disease getting worse and of experiencing a heart attack or dying from heart-related complications. People who stop smoking after being diagnosed have much better outcomes than those who continue.

Exercise, particularly supervised walking programs, is another essential part of treatment. Although it may seem counterintuitive to exercise when walking causes pain, regular physical activity actually helps improve symptoms over time. Medical guidelines recommend supervised exercise therapy, which typically involves group sessions led by a trainer. These programs usually consist of two hours of supervised exercise each week for three months. During exercise sessions, patients are encouraged to walk until they feel pain, rest until the discomfort goes away, and then start walking again. This "stop-start" method helps build up endurance and can significantly reduce leg pain over time.

Diet plays an important role as well. Eating a balanced diet that includes plenty of fruits, vegetables, and whole grains while limiting saturated fats, sodium, added sugars, and alcohol can help control cholesterol levels and blood pressure. Some evidence suggests that a Mediterranean-style diet, which emphasizes olive oil, nuts, beans, and fish while limiting red meat and processed foods, may be particularly beneficial for people with PAD.

Medications are a key component of standard treatment. Several types of drugs are commonly prescribed to help manage PAD and reduce the risk of complications. Antiplatelet agents such as aspirin or clopidogrel help prevent blood clots from forming around narrowed areas in the arteries. These medications are crucial because blood clots can suddenly and completely block an already narrowed artery, leading to severe complications.

Statins are cholesterol-lowering medications that work by reducing the production of LDL cholesterol (often called "bad cholesterol") in the liver. High cholesterol contributes to the buildup of plaque in artery walls, so controlling cholesterol levels can help slow the progression of PAD. Many people tolerate statins well, though some may experience side effects like muscle aches, indigestion, or headaches. These side effects often improve over time.

Antihypertensive medications, particularly angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), are used to control high blood pressure. These drugs work by affecting hormones that regulate blood pressure, helping to lower it and reduce strain on the arteries. Common side effects include dizziness, tiredness, headaches, and a persistent dry cough, though most of these effects diminish after a few days or weeks of use.

Some patients may also be prescribed a medication called cilostazol, which can help improve blood flow to the legs and reduce pain during walking. This drug works by widening blood vessels and preventing blood clots. It is typically taken twice daily and may make exercise more comfortable for people with PAD.

The duration of medical treatment for PAD is typically lifelong. Because the condition results from atherosclerosis (the buildup of fatty deposits in artery walls), which is a chronic process affecting blood vessels throughout the body, ongoing medication and lifestyle changes are necessary to prevent the disease from progressing and to reduce the risk of heart attack, stroke, and other complications.

In cases where lifestyle changes and medications do not adequately relieve symptoms, or when the disease has progressed to a severe stage, procedures to restore blood flow may be considered. Angioplasty is a minimally invasive procedure where a doctor inserts a thin tube called a catheter into an artery, usually through a small incision in the groin or arm. The catheter is guided to the narrowed section of the artery. A small balloon on the end of the catheter can be inflated to stretch open the narrowed area and flatten the plaque against the artery wall. Sometimes a stent, which is a small mesh tube, is placed inside the artery to help keep it open. Some procedures also use special catheters to remove plaque buildup. After the procedure, patients may go home the same day or stay in the hospital for one or two nights. Recovery is usually quick, with minimal restrictions on activity after a few days.

For more complex or severe blockages, bypass surgery may be recommended. During this operation, surgeons create a detour around the blocked section of artery using a blood vessel taken from another part of the body, often a vein from the leg. The new vessel is grafted onto the artery above and below the blockage, allowing blood to flow around the obstruction. Bypass procedures are more invasive than angioplasty but may provide longer-lasting results in certain situations.

Treatment in clinical trials

While standard treatments have helped many people manage peripheral arterial occlusive disease, researchers continue to explore new therapies and techniques that might offer even better outcomes. Clinical trials are research studies where doctors test promising new treatments to see if they are safe and effective before they become widely available. These studies are conducted in phases, each designed to answer specific questions about a new therapy.

Phase I trials focus primarily on safety. Researchers give a new treatment to a small group of people to see if it causes any harmful side effects and to determine the appropriate dose. Phase II trials involve more participants and aim to find out whether the treatment actually works to improve the condition or reduce symptoms. Phase III trials are larger studies that compare the new treatment to current standard treatments to see if the new approach offers any advantages.

Recent years have seen significant advances in the devices and techniques used to treat PAD. Researchers have been testing improved types of balloons, stents, and catheters that may help keep arteries open longer after a procedure. Some of these innovations include drug-eluting stents and drug-coated balloons. These devices are coated with medications that are slowly released into the artery wall after they are placed. The medication helps prevent scar tissue from forming inside the artery, which is one of the main reasons arteries can narrow again after a procedure. Studies have shown that these drug-coated devices may improve long-term results, particularly in smaller arteries like those in the thigh and below the knee.

Another area of active research involves developing new medications that target specific molecular pathways involved in atherosclerosis. Scientists are studying drugs that might reduce inflammation in artery walls, prevent plaque from building up, or even help dissolve existing plaque. Some of these experimental treatments work differently from current medications and might be used in combination with existing drugs to provide better symptom control and disease management.

Researchers are also exploring ways to improve the delivery of existing treatments. For example, some clinical trials are testing whether certain medications can be injected directly into or near the blocked artery to have a more targeted effect with fewer side effects throughout the body. Others are investigating whether combining different types of procedures, such as using both a balloon and a device to remove plaque, might give better results than either approach alone.

Clinical trials for PAD are conducted at medical centers and hospitals around the world, including in the United States, Europe, and other regions. To participate in a clinical trial, patients typically need to meet certain criteria, which might include having a specific stage of the disease, being within a certain age range, or not having certain other health conditions. Doctors carefully screen potential participants to ensure the study is appropriate for them and to protect their safety.

It is important to understand that treatments being tested in clinical trials are not yet proven to be effective, even though they show promise. The goal of these studies is to gather evidence about whether the new approach truly helps patients. Participants in clinical trials receive close monitoring and follow-up care, and they play a valuable role in advancing medical knowledge that may help future patients.

Most common treatment methods

  • Lifestyle modifications
    • Smoking cessation, which is the most important change for people with PAD
    • Supervised exercise therapy involving regular walking with a "stop-start" method to build endurance
    • Heart-healthy diet emphasizing fruits, vegetables, whole grains, and limiting saturated fats
    • Weight management to reach and maintain a healthy body weight
    • Regular physical activity performed daily to maintain benefits
  • Medication therapy
    • Antiplatelet agents (aspirin, clopidogrel) to prevent blood clots
    • Statins to lower cholesterol levels and slow plaque buildup
    • ACE inhibitors or ARBs to control blood pressure
    • Cilostazol to improve blood flow and reduce walking pain in some patients
  • Minimally invasive procedures
    • Balloon angioplasty to stretch open narrowed arteries
    • Stent placement to keep arteries open after angioplasty
    • Plaque removal using specialized catheters
    • Drug-eluting stents and drug-coated balloons to prevent re-narrowing
  • Surgical treatment
    • Bypass surgery using a vein or artery from another part of the body to create a detour around blocked sections
    • Open surgical procedures for severe or complex blockages

Did you know?

  1. More than half of an artery's interior must be blocked before symptoms typically appear, meaning many people have significant narrowing without knowing it.
  2. Black people face a higher risk of developing PAD compared to non-Hispanic white people, with the risk gap widening after age 50 in males and age 60 in females.
  3. Supervised exercise therapy can be just as effective as some medications for reducing leg pain, yet only a small percentage of healthcare budgets goes toward diagnostic and monitoring services for vascular conditions.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Peripheral arterial occlusive disease

Recruiting trials first

See all 17 trials →
Quick filters

17 clinical trials in this condition

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:Medical University Of Graz
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Clopidogrel
  • Sponsor:Fondation Hopital Saint Joseph
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Heparin Sodium
  • Sponsor:Aplagon Oy
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ALLOGENEIC REGULATORY MACROPHAGES
  • Sponsor:Ferring Ventures GmbH
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:FIBRIN
  • Sponsor:Medical University Of Warsaw
See all 17 trials →filters applied: condition = Peripheral arterial occlusive disease

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).